Berkeley, CA, United States of America

Pablo D T Valenzuela


Average Co-Inventor Count = 2.3

ph-index = 5

Forward Citations = 135(Granted Patents)


Location History:

  • Santiago, CL (2003)
  • Berkeley, CA (US) (2001 - 2006)

Company Filing History:


Years Active: 2001-2006

Loading Chart...
6 patents (USPTO):Explore Patents

Title: The Innovations of Pablo D T Valenzuela

Introduction

Pablo D T Valenzuela is a prominent inventor based in Berkeley, CA. He has made significant contributions to the field of biotechnology, holding a total of 6 patents. His work primarily focuses on the development of innovative proteins and receptors that have important applications in medical research and treatment.

Latest Patents

Valenzuela's latest patents include groundbreaking inventions such as multiple epitope fusion proteins. These proteins are designed for use in immunoassays and are characterized by a specific structural formula that allows for the incorporation of various amino acid sequences. Another notable patent involves the cloning and expression of a new receptor for fibroblast growth factor. This recombinant receptor is instrumental in inhibiting FGF activity and is useful for screening compounds that exhibit similar binding activity to FGF.

Career Highlights

Throughout his career, Valenzuela has been associated with Chiron Corporation, where he has contributed to various research initiatives. His innovative work has not only advanced scientific understanding but has also paved the way for new therapeutic approaches in medicine.

Collaborations

Valenzuela has collaborated with esteemed colleagues such as David Y Chien and Michael C Keifer. These partnerships have fostered a collaborative environment that enhances the potential for groundbreaking discoveries.

Conclusion

Pablo D T Valenzuela's contributions to biotechnology through his patents and collaborations highlight his role as a leading inventor in the field. His work continues to influence medical research and innovation.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…